65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79718D0592
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 95% complete
IDV ceiling
$49,956,905.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs issued a Federal Supply Schedule contract to H2-Pharma LLC under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on October 1, 2018, for drugs, pharmaceuticals, and hematology-related products with a ceiling value of $49,956,905.

The contract carries no set-aside category and operates as a multiple-award schedule vehicle, allowing VA and other federal agencies to place orders against the contractor's GSA-approved price list without conducting individual competitions. The contract is extended to March 31, 2027. Performance occurs at locations supporting the Veterans Integrated Service Network 12.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00044 · Temp EXT $0
Supplemental Agreement for work within scope P00043 · NDC change $0
Supplemental Agreement for work within scope P00042 · Converting to evergreen contract $0
Supplemental Agreement for work within scope P00041 · NDC change $0
Supplemental Agreement for work within scope P00040 · 42-2A product deletion (7 items) $0
Supplemental Agreement for work within scope P00039 · 2026 public law pricing update $0
Supplemental Agreement for work within scope P00038 · NDC change for 2 items. Ndcs to remain on contract until stock is completely exhausted. $0
Supplemental Agreement for work within scope P00036 · Temporary contract extension 10-01-2025 - 10-01-2026 $0
Supplemental Agreement for work within scope P00035 · (42-2A) transfer product addition $0
Supplemental Agreement for work within scope P00034 · 42-2A product addition (orlistat) $0
Supplemental Agreement for work within scope P00033 $0
Supplemental Agreement for work within scope P00032 · 42-2A product addition $0
Supplemental Agreement for work within scope P00031 · Public law update 2025 $0
Supplemental Agreement for work within scope P00030 · NDC code change $0
Supplemental Agreement for work within scope P00029 · Permanent price reduction $0
Supplemental Agreement for work within scope P00028 · NDC change $0
Supplemental Agreement for work within scope P00027 · Administrative change $0
Supplemental Agreement for work within scope P00026 · Temporary contract extension $0
Supplemental Agreement for work within scope P00025 · Public law update 2024 $0
Supplemental Agreement for work within scope P00022 · Permanent price reduction $0
Supplemental Agreement for work within scope P00024 $0
Supplemental Agreement for work within scope P00023 · NDC change $0
Supplemental Agreement for work within scope P00021 $0
Supplemental Agreement for work within scope P00020 · Product addition $0
Supplemental Agreement for work within scope P00019 · Temporary contract extension $0
Supplemental Agreement for work within scope P00018 · Product addition modification. $0
Supplemental Agreement for work within scope P00017 · Public law 2023 update $0
Supplemental Agreement for work within scope P00016 · Product addition modification. $0
Supplemental Agreement for work within scope P00015 · Product addition $0
Supplemental Agreement for work within scope P00014 · Administrative change - point of contact $0
Supplemental Agreement for work within scope P00013 · Public law 2022 pricing update $0
Supplemental Agreement for work within scope P00012 · Product deletion $0
Supplemental Agreement for work within scope P00011 · POC change $0
Supplemental Agreement for work within scope P00010 · Point of sales contact change $0
Supplemental Agreement for work within scope P00009 · PL 2021 $0
Supplemental Agreement for work within scope P00007 · NDC change on etopophos. $0
Supplemental Agreement for work within scope P00008 · Alternate POC. $0
Supplemental Agreement for work within scope P00006 · Product addition of cytovene at permanent FCP. $0
Supplemental Agreement for work within scope P00005 · Public law 2020 pricing updates. $0
Supplemental Agreement for work within scope P00004 · Admin and IFF point of contact change $0
Supplemental Agreement for work within scope P00003 · Product addition of etopophos at permanent FCP. $0
Supplemental Agreement for work within scope P00002 · Address/POC/IFF/agent update $0
Supplemental Agreement for work within scope P00001 · Public law 2019. $0
Original award $0
Show all 44

Quick answers

Who was awarded contract 36F79718D0592?

36F79718D0592 was awarded to H2-Pharma LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 1, 2018.

How much is contract 36F79718D0592 worth?

36F79718D0592's own ceiling is $49,956,905.

Who can order from contract 36F79718D0592?

36F79718D0592 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79718D0592 part of a contract vehicle?

Yes. 36F79718D0592 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79718D0592 competed?

The extent of competition for 36F79718D0592 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV